To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Investors chew on Jaws’ stunning $4.4bn SPAC deal for Cano Health
The deal highlights the fact that PIPE investors in a SPAC are underwriting to different financial metrics than prospective PE buyers – leading to much larger valuations in some cases.
